Upstate Active Clinical Trials
Study Title:LCH-IV International Collaborative Treatment Protocol for Children and Adolescents with
Langerhans Cell Histiocytosis
What is the purpose of the study?In this LCH-IV study, researchers want to find out if prolonging the treatment even further (from 12 months to 24 months) and adding another drug called 6-mercaptopurine will be beneficial. The goals of this study are to find out if these changes will result in fewer patients having a relapse of their LCH, and fewer patients having long-term disease-related problems.
Upstate Institutional Review Board (IRB) Number:1020891
Study Phase:Phase II/III
Patient Age Group:Children
Principal Investigator:Melanie A Comito
Who can I contact for more information?
Name: Karen B Bilynsky